Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 11, 2026 · Filed Nov 13, 2026
Castle Biosciences's Chief Commercial Officer sold $112K of Castle Biosciences shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$112,049
Shares × reported transaction price
6 days after results of Nov 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $33.99 on Nov 11, 2026, 87% above its 52-week low and 21% below its high, after a 4% drop over the previous 30 trading days
52-week range $18.15 (May 13, 2026) to $43.04 (Jan 26, 2026), 64% of the way up, from 250 adjusted closes. 30 trading days earlier: $35.53 on Sep 30, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider filing
Traded Nov 11 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Nov 11 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Tobin Juvenal (Officer) plans to sell ~$112K of Castle Biosciences
Planned, from payEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
